Researchers



Results 1-20 of 91
Issue DateTitleAuthor(s)TypeМp-cat.
2025Novel 1-benzhydryl piperazine scaffoldbased HDAC inhibitor b7 induces synergistic antiproliferative effect with vemurafenib in colorectal cancer cells harboring BRAF mutationVuletić, Ana  ; Martinović, Mirjačić Katarina  ; Srdić-Rajić, Tatjana  ; Miletić, Nevena Tišma  ; Đurić, Ana  ; Nikolić, Katarina  ; Ružić, Dušan  ; Čavić, Milena  Conference Paper
Mp. category will be shown later
2025Pioneering first-in-class HDAC-ROCK inhibitors as potential multitarget anticancer agentsBeljkaš, Milan  ; Ružić, Dušan  ; Djurić, Ana  ; Vuletić, Ana  ; Nchugoua Tchiehe, Guilaine; Jallet, Corinne; Cadet-Daniel, Veronique; Arimondo, Paola B; Santibanez, Juan F.  ; Srdić-Rajić, Tatjana  ;
Nikolić, Katarina  ; Oljačić, Slavica  ; Petković, Miloš  ;
Article
22M22
2025A computational framework for the design and development of ERK2 and multi-target ERK2/HDAC inhibitorsCebzan, Alen; Ružić, Dušan  ; Đoković, Nemanja  ; Stanković, Branislav  ; Nikolić, Katarina  Article
21M21
2025P 01 Identification of Dual-Acting HDAC Inhibitors for Pancreatic Cancer Treatment through Drug Synergy Predictions and Molecular ModelingĐoković, Nemanja  ; Ilić, Aleksandra  ; Čebzan, Alen  ; Radović, Branko  ; Ružić, Dušan  ; Beljkaš, Milan  ; Đurić, Ana  ; Srdić-Rajić, Tatjana  ; Oljačić, Slavica  ; Nikolić, Katarina  Conference Paper
Mp. category will be shown later
2025Application of Separation Methods in Biomimetic Studies and the Determination of Physicochemical Properties of Imidazoline and αAdrenergic Receptor LigandsOljacic, Slavica  ; Popovic-Nikolic, Marija  ; Obradović, Darija  ; Ruzic, Dusan; Vucicevic, Jelica; Mitja Krizman; Irena Vovk; Popovic, Gordana  ; Nikolic, Katarina  Conference Paper
Mp. category will be shown later
2025Towards a pan-HDAC chemoproteomics drug profiling assayDimitriadou, Aspasia; Lechner, Severin; Sarnari, Chiara; Radović, Branko  ; Ružić, Dušan  ; Karousi, Paraskevi; Zoidakis, Jérôme; Courraud, Julie; Médard, GuillaumeConference Paper
Mp. category will be shown later
2025Exploring the effect of bioenvironment on the ionization of drugs using the membrane mimetic properties of differently charged micellesPopović-Nikolić, Marija  ; Popović, Gordana  ; Oljačić, Slavica  ; Nikolić, Katarina  ; Agbaba, Danica  Conference Paper
Mp. category will be shown later
2025A pan-HDAC chemoproteomics assay to profile drugsDimitriadou, Aspasia; Lechner, Severin; Sarnari, Chiara; Radović, Branko  ; Ružić, Dušan  ; Karousi, Paraskevi; Zoidakis, Jérôme; Courraud, Julie; Médard, GuillaumeConference Paper
Mp. category will be shown later
2025Pharmacological manipulation of liver fibrosis progression using novel HDAC6 inhibitorsBorrello, Maria Teresa; Ruzic, Dusan  ; ...; Radovic, Branko  ; ...; Petkovic, Milos R  ; Nikolic, Katarina M  ; ...; (broj, koautora 26)Article
21M21
2024Strengthening the epigenetic and signaling axis: Dual HDAC/ROCK inhibitors as a new therapeutic strategy in cancer treatmentBeljkaš, Milan  ; Petković, Miloš  ; Ružić, Dušan  ; Oljačić, Slavica  ; Nikolić, Katarina  ; Arimondo, Paola B; Srdić-Rajić, Tatjana  ; Vuletić, Ana  ; Jelić Mariokov Đurić, Ana  Conference Paper
Mp. category will be shown later
2024Integrative Framework for Developing Innovative SIRT2 InhibitorsĐoković, Nemanja  ; Rahnasto‐Rilla, Minna; Đurić, Ana  ; Ružić, Dušan  ; Petković, Miloš  ; Srdić Rajić, Tatjana  ; Lahtela-Kakkonen, Maija; Nikolić, Katarina  Conference Paper
Mp. category will be shown later
2024Discovery of dual-acting HDAC inhibitors for the treatment of pancreatic cancer by combining drug synergy and molecular modelingĐoković, Nemanja  ; Ilić, Aleksandra  ; Čebzan, Alen  ; Radović, Branko  ; Ružić, Dušan  ; Beljkaš, Milan  ; Đurić, Ana  ; Srdić-Rajić, Tatjana  ; Oljačić, Slavica  ; Nikolić, Katarina  Conference Paper
Mp. category will be shown later
2024Targeting noncoding RNAs to treat atherosclerosisSopić, Miron  ; Vladimirov, Sandra  ; Munjas, Jelena  ; Mitić, Tijana; Hall, Ignacio Fernando; Jušić, Amela; Ružić, Dušan  ; Devaux, YvanArticle
21a+M21a+
2023Screening of naphthalimides as antimetastatic agentsSánchez-Martín, Victoria; Ružić, Dušan  ; Castilla-Maldonado, Ignacio; Ortiz-González, Matilde; Soriano-Lerma, Ana; Linde-Rodríguez, Ángel; Pérez-Carrasco, Virginia; Ramirez-Macias, Inmaculada; Soriano, Miguel; Nikolić, Katarina  ;
García-Salcedo, Jose Antonio;
Conference Paper
Mp. category will be shown later
2023Discovery of novel HDAC inhibitors for therapy of triple-negative breast cancer – preclinical studyRužić, Dušan  ; Đoković, Nemanja  ; Santibanez, Juan  ; Pavić, Aleksandar  ; Ganesan, A.; Srdić- Rajić, Tatjana  ; Nikolić, Katarina  Conference Paper
Mp. category will be shown later
2023Computer-aided drug design of MAPK inhibitors by combined 3D-QSAR analysis and molecular dockingČebzan, Alen  ; Ružić, Dušan  ; Nikolić, Katarina  Conference Paper
Mp. category will be shown later
2023Targeting Histone Deacetylases 6 in Dual-Target Therapy of CancerBeljkas, Milan  ; Ilić, Aleksandra  ; Cebzan, Alen  ; Radović, Branko  ; Đoković, Nemanja  ; Ružić, Dušan  ; Nikolić, Katarina  ; Oljačić, Slavica  Article
21aM21a
2023Correlating basal gene expression across chemical sensitivity data to screen for novel synergistic interactors of HDAC inhibitors in pancreatic carcinomaNemanja Djokovic  ; Ana Djuric  ; Dusan Ruzic  ; Tatjana Srdic-Rajic  ; Katarina Nikolic  Article
21M21
2023Discovery of novel small molecule inhibitors of HDAC6 that suppress liver fibrosisBorrello, Maria Teresa; Ružić, Dušan  ; Oakley, Fiona; Nikolić, Katarina  ; Mann, Jelena; Mann, DerekConference Paper
Mp. category will be shown later
2023Towards the multitarget HDAC Inhibitors for the treatment of pancreatic carcinoma by joining the drug synergy predictions and the molecular modelingĐoković, Nemanja  ; Ilić, Aleksandra  ; Čebzan, Alen  ; Radović, Branko  ; Ružić, Dušan  ; Đurić, Ana  ; Srdić-Rajić, Tatjana  ; Nikolić, Katarina  Conference Paper
Mp. category will be shown later